FindTrial
Sign In

The study of Kallistatin-inhibiting endometriosis by regulating autophagy

The study of Kallistatin-inhibiting endometriosis by regulating autophagy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094063
Enrollment
Unknown
Registered
2024-12-16
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Observation group:None

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Endometriosis;

Exclusion criteria

Exclusion criteria: 1.Associated with other inflammatory and infectious diseases;

Design outcomes

Primary

MeasureTime frame
Kallistatin;—

Countries

China

Contacts

Public ContactLei Li

The Third Affiliated Hospital of Guangzhou Medical University

lileigo@foxmail.com+86 20 81291623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026